Cellectar Biosciences, Inc. (CLRB) SEC Filings — 2024

Filings

• Cellectar Biosciences Files 8-K on Exit Costs and Disclosures — 8-K · Dec 11, 2024
• Cellectar Biosciences Files 8-K on Financials — 8-K · Nov 18, 2024
• Cellectar Biosciences Files Q3 2024 10-Q — 10-Q · Nov 18, 2024
• Cellectar Biosciences Files 8-K — 8-K · Nov 15, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Cellectar Biosciences Files 8-K — 8-K · Nov 1, 2024
• Cellectar Biosciences Files 2023 10-K Amendment — 10-K/A · Oct 29, 2024
• Cellectar Biosciences Faces Nasdaq Delisting Risk — 8-K · Aug 23, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Aug 14, 2024
• Cellectar Biosciences Files 8-K on Operations — 8-K · Aug 13, 2024
• Cellectar Biosciences Restates Financials — 8-K · Aug 9, 2024
• Cellectar Biosciences to be Acquired for $10.5M — 8-K · Jul 23, 2024
• Cellectar Biosciences Files 8-K on Securities Purchase Agreement — 8-K · Jul 22, 2024
• Daiichi Sankyo to Acquire Cellectar Biosciences for $31.7M — 8-K · Jul 11, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Jul 11, 2024
• Cellectar Biosciences Enters Material Definitive Agreement — 8-K · Jun 25, 2024
• Cellectar Biosciences Files 8-K on Governance and Compensation — 8-K · Jun 14, 2024
• Cellectar Biosciences Files 8-K on Financials — 8-K · May 14, 2024
• Cellectar Biosciences Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
• Cellectar Biosciences Announces 2024 Annual Meeting of Stockholders on June 14 — DEF 14A · Apr 26, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Apr 25, 2024
• Cellectar Biosciences Files 10-K/A Amendment — 10-K/A · Apr 1, 2024
• Cellectar Biosciences Files 8-K on Financials — 8-K · Mar 27, 2024
• Cellectar Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 27, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Cellectar Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• AIGH Capital Mgmt. Holds 2.66M Shares of Cellectar Biosciences — SC 13G/A · Feb 7, 2024
• Cellectar Biosciences Files 8-K for 'Other Event,' Signals Potential Corporate Action — 8-K · Feb 2, 2024
• ADAR1 Partners Discloses 9.9% Stake in Cellectar Biosciences — SC 13G · Jan 31, 2024
• Cellectar Biosciences Signals Securities Communication via 8-K — 8-K · Jan 25, 2024
• Cellectar Biosciences Confirms Nasdaq Listing for CLRB Stock — 8-K · Jan 9, 2024